Efficient and Sensitive Bisulfite-Free Methylation Detection Approach for Low-Abundance and Highly Fragmented cfDNA
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c01974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Linqing Zhen und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, P. R. China. Hauptthemen laut MEDLINE: DNA Methylation, Cell-Free Nucleic Acids, Sulfites, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Science and Technology Plan Project of Taizhou, Fundamental Research Funds for the Central Universities, Medical and Health Technology program of Zhejiang Province.
Abstract (Originalsprache)
Circulating cell-free DNA (cfDNA) has emerged as a promising noninvasive diagnostic tool for liquid biopsy, with abnormal DNA methylation serving as a key biomarker for cancer screening and early diagnosis. However, the low abundance and high fragmentation of cfDNA present significant challenges to the sensitivity and specificity of the current methylation detection methods. We aim to develop a highly sensitive methylation detection method for fragmented cfDNA that does not require bisulfite conversion. In this study, we combined double restriction enzyme digestion with specific terminal-mediated polymerase chain reaction (STEM-PCR) to establish a cfDNA methylation detection method, namely, the dRE-STEM method. The dRE-STEM method could detect methylated cfDNA on the PCR platform without the need for cumbersome bisulfite conversion. A case-control study was conducted to validate the diagnostic value of colorectal cancer (CRC)-related specific methylated locates using the dRE-STEM method. The dRE-STEM method successfully detected methylation ratios as low as 3% using just 4 ng of cfDNA input, and the best diagnostic model achieved 80.2% (95% CI, 70.6-87.4%) sensitivity and 80.9% (95% CI, 71.9-87.7%) specificity for CRC, significantly outperforming conventional protein markers. The dRE-STEM method offers a promising approach for accurate methylation quantification in low-abundance, highly fragmented cfDNA, making it particularly suitable for routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, P. R. China.
- Hefei Cancer Early Screening Innovation Technology Institute, Hefei, Anhui 230031, P. R. China.
- Medical Community of Linhai First People's Hospital, Zhejiang 317099, P. R. China.
- Shanghai Healzone Biotechnology Co., LTD, Shanghai 200000, P. R. China.
- Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, P. R. China.
ORCID-Profile: Hong Xu
Förderung
- Science and Technology Plan Project of Taizhou
- Fundamental Research Funds for the Central Universities
- Medical and Health Technology program of Zhejiang Province
- Key projects of special development funds for Shanghai Zhangjiang National Innovation Demonstration Zone
Zitieren
APA
Zhen, L., Yang, H., Huang, Y., Li, C., Ren, W., Xu, Z., Guo, S., Wang, Y., Fang, Z., Chen, C., Zhang, M., Nie, J., Gu, H., Zhong, M., & Xu, H. (2025). Efficient and Sensitive Bisulfite-Free Methylation Detection Approach for Low-Abundance and Highly Fragmented cfDNA. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c01974
Vancouver
Zhen L, Yang H, Huang Y, Li C, Ren W, Xu Z, et al. Efficient and Sensitive Bisulfite-Free Methylation Detection Approach for Low-Abundance and Highly Fragmented cfDNA. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c01974
BibTeX
@article{Zhen2025,
author = {Zhen, Linqing and Yang, Hao and Huang, Yizhou and Li, Chao and Ren, Wei and Xu, Zhengguo and Guo, Shiwei and Wang, Yuguang and Fang, Zhaoqi and Chen, Cang and Zhang, Min and Nie, Jianing and Gu, Hongchen and Zhong, Ming and Xu, Hong},
title = {Efficient and Sensitive Bisulfite-Free Methylation Detection Approach for Low-Abundance and Highly Fragmented cfDNA},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c01974}
}
EUVIMED